Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Gynecology

Free Subscription 22.09.2025 5 Am J Obstet Gynecol 1 Am J Surg Pathol 1 Ann Oncol 1 BMC Urol 1 BMJ 2 Br J Cancer 1 Diagn Cytopathol 1 Eur J Cancer 3 Eur J Obstet Gynecol Reprod Biol 3 Fertil Steril 1 Gynecol Endocrinol 7 Gynecol Oncol 1 Int J Cancer 3 Int J Gynaecol Obstet 1 JAMA 2 Obstet Gynecol 1 Oncogene 6 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Obstet Gynecol

1. OSTENFELD EB, Bjornholt SM, Sponholtz SE, Froding LP, et al
   Long-term lymphedema and quality of life following lymph node staging in early cervical cancer: 3 years follow-up in the prospective multicenter SENTIREC CERVIX study.
   Am J Obstet Gynecol. 2025 Sep 15:S0002-9378(25)00674.
   PubMed         Abstract available
   
   
2. MELAKE A, Sahin L, Yao L
   Solutions to Pregnancy Safety Information (Reply to Letter-to-the-Editor).
   Am J Obstet Gynecol. 2025 Sep 12:S0002-9378(25)00670.
   PubMed        
   
   
3. PAULA RD, Alejandro SL, Sergio MI
   Impact of exercise training during pregnancy on maternal biomarkers: A systematic review.
   Am J Obstet Gynecol. 2025 Sep 12:S0002-9378(25)00675.
   PubMed         Abstract available
   
   
4. ROUSE KJ, Chen L, Layne TM, Xu X, et al
   Uterine Cancer Diagnosis at Age 65: Onset of Medicare Eligibility and Impact of Medicaid Expansion.
   Am J Obstet Gynecol. 2025 Sep 12:S0002-9378(25)00672.
   PubMed         Abstract available
   
   
5. YAN L, Zhu C, Xia W, Wang Y, et al
   Levonorgestrel intrauterine system vs. hysteroscopic niche resection for postmenstrual spotting: a three-year randomized trial follow-up.
   Am J Obstet Gynecol. 2025 Sep 11:S0002-9378(25)00663.
   PubMed         Abstract available
   
   

   
   Am J Surg Pathol

6. TALIA KL, Hawkes D, Zhang G, Jamison J, et al
   HPV42: A Common Low-Risk HPV Type Associated With Distinctive Cervicovaginal and Cutaneous Neoplasia.
   Am J Surg Pathol. 2025;49:992-1003.
   PubMed         Abstract available
   
   

   
   Ann Oncol

7. RYU SY, Deng W, Albuquerque K, Koh WJ, et al
   Randomized Phase III Trial of Adjuvant Radiation versus Chemoradiation in Intermediate-Risk, Early-stage Cervical Cancer following Radical Hysterectomy and Lymphadenectomy: Results from NRG Oncology/GOG-263/KGOG1008.
   Ann Oncol. 2025 Sep 12:S0923-7534(25)04700-3. doi: 10.1016/j.annonc.2025.
   PubMed         Abstract available
   
   

   
   BMC Urol

8. SHOUKRY A, ElKassar Y, Hezagirwa MK, El-Said R, et al
   Retraction Note: Efficacy of lactoferrin in preventing recurrent urinary tract infections in pregnant Egyptian women: a randomized controlled trial.
   BMC Urol. 2025;25:230.
   PubMed        
   
   

   
   BMJ

9. TAYLOR L
   Almost $10m of "incinerated" US aid contraceptives found safe, but still at risk.
   BMJ. 2025;390:r1951.
   PubMed        
   
   

   
   Br J Cancer

10. WU R, Arendse KD, Hamdani T, Walter FM, et al
    Cost-effectiveness of CA125- and age-informed risk-based triage for ovarian cancer detection in primary care.
    Br J Cancer. 2025 Sep 17. doi: 10.1038/s41416-025-03166.
    PubMed         Abstract available
    
    
11. ARENDSE KD, Walter FM, Abel G, Rous B, et al
    CA125 and age-based models for ovarian cancer detection in primary care: a population-based external validation study.
    Br J Cancer. 2025 Sep 17. doi: 10.1038/s41416-025-03165.
    PubMed         Abstract available
    
    

    
    Diagn Cytopathol

12. FERREIRA JE, Chiang N, Jing X, Smola B, et al
    In-Depth Assessment of Cytologic Features in 106 Cervical Papanicolaou Tests of Transgender Male Patients on Testosterone: An Institutional Experience.
    Diagn Cytopathol. 2025 Sep 15. doi: 10.1002/dc.70018.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

13. RAMOS-CASALLAS A, Cardona-Mendoza A, Perdomo-Lara SJ, Rico-Mendoza A, et al
    Performance evaluation of machine learning models in cervical cancer diagnosis: Systematic review and meta-analysis.
    Eur J Cancer. 2025;229:115768.
    PubMed         Abstract available
    
    

    
    Eur J Obstet Gynecol Reprod Biol

14. MALLIA P, Savona-Ventura C, Mahmood T
    The ethics of publishing on social media-: The example of obesity - an invited review by the Standing Committee on Standards of Care and Position Statements of the European Board and College of Obstetrics and Gynaecology (EBCOG).
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114710.
    PubMed         Abstract available
    
    
15. HINKSON L, Okasha M, Tutschek B, Henrich W, et al
    Sonography only, few internal examinations (SOFIE): Birth progress in normal deliveries followed with intrapartum ultrasound.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114714.
    PubMed         Abstract available
    
    
16. ZOU Q, Luo P, Huang F, Yang G, et al
    Blastocoele re-expansion immediately after warming is a strong hallmark for predicting pregnancy outcome in single vitrified-warmed blastocyst transfer.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114713.
    PubMed         Abstract available
    
    

    
    Fertil Steril

17. SHARAFUTDINOV K, Hilpert J, Burghaus R, Diedrich C, et al
    Polycystic ovary syndrome and elevated body mass index independently increase type 2 diabetes risk with obesity-mediated risk dominating: a real-world data analysis of US patients.
    Fertil Steril. 2025 Sep 12:S0015-0282(25)01910.
    PubMed         Abstract available
    
    
18. PENA AS, Witchel SF
    Update on diagnosis of polycystic ovary syndrome during adolescence.
    Fertil Steril. 2025 Sep 11:S0015-0282(25)01901.
    PubMed         Abstract available
    
    
19. KELLY S, Hirshfeld-Cytron J
    Improved outcomes in euploid single embryo transfer: let "natural" takes its course for endometrial preparation?
    Fertil Steril. 2025 Sep 11:S0015-0282(25)01902.
    PubMed        
    
    

    
    Gynecol Endocrinol

20. CHEN W, Xu D, Shao X, Song Q, et al
    Meta-analysis of the effects of semaglutide on body mass index (BMI) and blood lipid levels in polycystic ovary syndrome patients.
    Gynecol Endocrinol. 2025;41:2553052.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

21. MULLEN MM, Arend RC
    From one-size-fits all to biology-driven care: Emerging paradigms in gynecologic oncology.
    Gynecol Oncol. 2025;200:A1-A2.
    PubMed        
    
    
22. JAEGER A, Hampl M, Prieske K, Eulenburg C, et al
    Risk for non-sentinel metastases in the contralateral groin in patients with a unilateral positive sentinel lymph node in primary vulvar cancer- a subgroup analysis of the AGO-VOP.2 QS Vulva Study.
    Gynecol Oncol. 2025;200:8-13.
    PubMed         Abstract available
    
    
23. SCHAAFSMA M, Schuurman TN, Bekkers RLM, Dunne FR, et al
    The risk for residual AIS/CIN3+ after the first conservative surgical procedure for cervical adenocarcinoma in situ - A Dutch retrospective cohort study.
    Gynecol Oncol. 2025;200:44-50.
    PubMed         Abstract available
    
    
24. MATSUBARA M, Otani T, Kawakami F, Koike A, et al
    Cervical adenocarcinoma risk stratification using histotype and invasion pattern: a multicenter retrospective study by the KAMOGAWA Study Group.
    Gynecol Oncol. 2025;200:112-121.
    PubMed         Abstract available
    
    
25. NEIBART SS, Lin LL, Einstein MH, Teoh D, et al
    Minimum standards for radiation therapy in the treatment of cervical cancer in the U.S.: A consensus statement by SGO, ASTRO, and ABS addressing the WHO Cervical Cancer Elimination Campaign goals.
    Gynecol Oncol. 2025;200:180-185.
    PubMed         Abstract available
    
    
26. NEIBART S, Zhou N, Chino J, Earles T, et al
    Health equity, disparities, and barriers to cervical cancer care in the U.S.: A consensus statement by SGO, ACOG, ASCCP, ASTRO, and ABS addressing the WHO cervical Cancer elimination campaign goals related to treatment.
    Gynecol Oncol. 2025;200:186-192.
    PubMed         Abstract available
    
    
27. ZHOU N, Beavis AL, Lin LL, Neibart SS, et al
    Embracing and implementing the WHO cervical cancer elimination campaign goals: A consensus statement by SGO, ACOG, ASCCP, ASTRO, and ABS on minimum quality care standards for cervical cancer patients in the U.S.
    Gynecol Oncol. 2025;200:193-202.
    PubMed         Abstract available
    
    

    
    Int J Cancer

28. ULLAH A, Chen Y, Shen Y, Shen B, et al
    Chemotherapy as a double-edged sword: Modulation of tumor-associated cytokine and chemokine responses in ovarian cancer.
    Int J Cancer. 2025 Sep 15. doi: 10.1002/ijc.70132.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

29. LIN XS, Zhang XX, Chen J, Ning LL, et al
    Transverse parallel compression suture with endotracheal tube tamponade for management of hemorrhage in complete placenta previa: A retrospective study.
    Int J Gynaecol Obstet. 2025 Sep 16. doi: 10.1002/ijgo.70535.
    PubMed         Abstract available
    
    
30. JITTRA K, Chatchawet W, Chunuan S
    Effects of a goal attainment program via line OA on self-care behaviors and hematocrit in pregnant adolescents with anemia: A quasi-experimental study.
    Int J Gynaecol Obstet. 2025 Sep 15. doi: 10.1002/ijgo.70536.
    PubMed         Abstract available
    
    
31. LIN M, Mao D, Lian W, Hu KL, et al
    The impact of routine chronic endometritis screening on clinical pregnancy outcomes in patients first receiving in vitro fertilization or intracytoplasmic sperm injection: A retrospective cohort study.
    Int J Gynaecol Obstet. 2025 Sep 15. doi: 10.1002/ijgo.70435.
    PubMed         Abstract available
    
    

    
    JAMA

32. VOELKER R
    What Is Endometriosis?
    JAMA. 2025 Sep 18. doi: 10.1001/jama.2025.14241.
    PubMed        
    
    

    
    Obstet Gynecol

33. KLUMPNER TT, Arnolds DE, Kountanis JA, Colquhoun DA, et al
    Pregnancy-Related Mortality in California Due to Obstetric Hemorrhage.
    Obstet Gynecol. 2025;146:e53-e54.
    PubMed        
    
    
34. PANCARO C
    Pregnancy-Related Mortality in California due to Obstetric Hemorrhage.
    Obstet Gynecol. 2025;146:e53.
    PubMed        
    
    

    
    Oncogene

35. LIU J, Ning J, Wang Y, He X, et al
    FOXA2 sensitizes endometrial carcinoma to progestin-mediated conservative therapy by triggering PR transcriptional activation.
    Oncogene. 2025 Sep 13. doi: 10.1038/s41388-025-03564.
    PubMed         Abstract available
    
    

    
    PLoS One

36. LEE JO, Kim CY, Lee S, Chung JH, et al
    Multi-cancer analysis of histopathologic MSI screening based on digital histology image.
    PLoS One. 2025;20:e0332034.
    PubMed         Abstract available
    
    
37. SANAMI S, Aghaamoo S, Ahmad S, Fazli A, et al
    Using systems biology and drug repositioning approaches to discover FDA-approved drugs candidates for endometriosis treatment.
    PLoS One. 2025;20:e0330841.
    PubMed         Abstract available
    
    
38. CHEN D, Wu H, Huang F, Tan K, et al
    Prognostic follow-up of high-grade squamous intraepithelial lesions of the cervix near the conization margin: A retrospective cohort study.
    PLoS One. 2025;20:e0331184.
    PubMed         Abstract available
    
    
39. OLUBODUN T, Olaniran A, Awowole IO, Ohazurike E, et al
    Practice of opportunistic cervical cancer screening and health education among health workers in Ogun State, Nigeria: A qualitative study of barriers and facilitators.
    PLoS One. 2025;20:e0316883.
    PubMed         Abstract available
    
    
40. MWANGI JH, Mbeje PN, Mtshali GN
    Exploring the roles of male partners in the transmission, prevention and control of cervical cancer in Central Kenya: A qualitative study.
    PLoS One. 2025;20:e0324575.
    PubMed         Abstract available
    
    
41. LIU J, Cai Y, Li J, Zhang X, et al
    Global and Chinese epidemiologic study of polycystic ovary syndrome in women of childbearing age, 1990-2021, and projections to 2035: Based on the Global Burden of Disease 2021 study.
    PLoS One. 2025;20:e0329090.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.